Worldwide, cervical cancer is the second most common cancer of women. Less-developed
countries bear the greatest burden in terms of morbidity and mortality, largely due to the lack …

Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide.
Primary prevention thorough vaccination si able to reduce the burden of HPV-related …

Background: Cervical cancer is the second largest cause of cancer deaths in women
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …

Universal deployment of organized or opportunistic screening with Pap cytology in high and
middle income countries has been the primary reason for the substantial reductions in …

Prophylactic vaccination with human papillomavirus (HPV) virus-like particle (VLP) vaccines
against HPV 16 and HPV 18, which are the cause of 70% or more of cervical cancers in …

Introduction: Identification of human papillomavirus (HPV) as the etiologic factor of cervical,
anogenital, and a subset of head and neck cancers has stimulated the development of …

Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …

Human papillomavirus (HPV) is causatively associated with cervical cancer (CC), the fourth
most common malignant disease of women worldwide. The introduction of first generation …

Benign and malignant disease caused by HPV (human papillomavirus) constitutes a global
public health problem. Genital warts are the commonest viral sexually transmitted infection …

Human papilloma virus (HPV) infections, which are common, produce epithelial lesions of
the nongenital and genital skin and mucous membranes. Although most infections are …